DAS
AVDL

Diversify Advisory Services’s Avadel Pharmaceuticals AVDL Stock Holding History

Diversify Advisory Services’s Portfolio AVDL Stock Details AVDL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-10,138
Closed -$139K – 620
2024
Q3 		$139K Sell
10,138
-2,958
-23% -$45.1K 0.01% 617
2024
Q2 		$208K Sell
13,096
-19,267
-60% -$314K 0.01% 600
2024
Q1 		$539K Buy
+32,363
New +$482K 0.03% 403

Other funds holding AVDL

Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
GJL
Gendell Jeffrey L $7.34B AUM 183.72% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PCH
Polar Capital Holdings London, United Kingdom $28.2B AUM 115.26% 1-Year Est. Return
TSC
Two Seas Capital Rye, New York $7.15B AUM 169.27% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
WE
Wealth Effects Boston, Massachusetts $370M AUM 97.79% 1-Year Est. Return

Diversify Advisory Services's AVDL Position: Q4 2024 in Review

Diversify Advisory Services sold out of Avadel Pharmaceuticals (AVDL) in Q4 2024, closing a stake of 10,138 shares — an estimated $139K sold.

Diversify Advisory Services first reported a position in AVDL in Q1 2024 and held it in 3 quarters. The position peaked at $539K in Q1 2024. 159 funds tracked by Wall St. Rank hold AVDL as of Q4 2024.

  • Diversify Advisory Services reported no remaining Avadel Pharmaceuticals position as of Q4 2024 after selling out during the quarter.
  • Diversify Advisory Services sold 10,138 Avadel Pharmaceuticals shares in Q4 2024, an estimated $139K.
  • Diversify Advisory Services first reported a position in Avadel Pharmaceuticals in Q1 2024 and held it in 3 quarters.
  • Diversify Advisory Services's Avadel Pharmaceuticals position peaked at $539K in Q1 2024.
  • 159 funds tracked by Wall St. Rank held Avadel Pharmaceuticals as of Q4 2024.

Based on Diversify Advisory Services's 13F filing for Q4 2024, filed 16 Jan 2025.